RSV vaccines slash infections in data showing staggering success
New data confirms that RSV vaccines and monoclonal antibody injections are significantly reducing hospitalizations for the respiratory virus.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
2 publishers have covered this in 3 articles since 9 Nov 2026. Quartz published first, on 9 November at 20:33 UTC; Nature followed 51h 27m later. The most recent article, from Nature, appeared on 12 November at 00:00 UTC.
Outlets reporting it: Nature (major outlet), Quartz.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- CDC